White Lyophilized Powder bFGF Growth Factor Repair Damaged Skin Cells 17KD Human FGF2

White Lyophilized Powder Basic Fibroblast Growth Factor BFGF Repair Damaged Skin Cells​

Description

bFGF can improve the cell growth microenvironment and promote the synthesis of deep elastic fibers and collagen, so as to restore the skin with elasticity and make the skin slides tenderly. It can also promote the growth and development of fibroblasts and constantly replace the aging cells with new cells, so as to achieve the anti-wrinkle and wrinkle removal effect. In addition, bFGF can not only stimulate the formation and epithelialization of skin granulation tissue, but also regulate collagen degradation and renewal, thereby reducing wound healing time and reduce the scar formation.

Quick Details

1. CAS No.: 106096-93-9
2. Other Names: Plant-derived bFGF, OsrhbFGF, rbFGF, recombinant bFGF, bFGF, FGF2, FGF-β
3. EINECS No.: 274-272-6
4. Brand Name: Oryzogen
5. Model Number: HYC005M01
6. Physical Appearance: White lyophilized powder
7. Biological Activity: The ED₅₀ is ≤1ng/ml determined by a cell proliferation assay using
8. Restrictions: FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY

Advantages

1. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen Biotech has strong capability in developing a series of biological products.

2. Healthgen Biotech recombinant bFGF is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease.

3.  Healthgen Biotech has a professional quality control department, in which 50% of them have master's degree or higher. There are 14 employees in the quality department, 9 of them are in QA and 5 are in QA. All of them have rich experience in analysis research or quality inspection. Half of them have graduated diploma. Every year there are more than 50 training courses, which cover GMP, SOP, specification, hygiene, QA, QC issues, etc.

Supplemental Description

FGF basic is a member of the FGF family of at least 23 related mitogenic proteins which show 35-60% amino acid conservation. FGF acidic and basic, unlike the other members of the family, lack signal peptides and are apparently secreted by mechanisms other than the classical protein secretion pathway. FGF basic has been isolated from a number of sources, including neural tissue, pituitary, adrenal cortex, corpus luteum, and placenta. This factor contains four cysteine residues, but reduced FGF basic retains full biological activity, indicating that disulfide bonds are not required for this activity. A variety of forms of FGF basic are produced as a result of N-terminal extensions. These extensions affect localization of FGF basic in cellular compartments but do not affect biological activity. Binding of FGF to heparin or cell surface heparan sulfate proteoglycans is necessary for binding of FGF to high affinity FGF receptors. FGF acidic and basic appear to bind to the same high affinity receptors and show a similar range of biological activities. FGF basic stimulates the proliferation of all cells of mesodermal origin and many cells of neuroectodermal, ectodermal, and endodermal origin. FGF basic induces neuron differentiation, survival, and regeneration. FGF basic also modulates embryonic development and differentiation. These observed in vitro functions of FGF basic suggest FGF basic may play a role in vivo in the modulation of such normal processes as angiogenesis, wound healing and tissue repair, embryonic development and differentiation, and neuronal function and neural degeneration. Additionally, FGF basic may participate in the production of a variety of pathological conditions resulting from excessive cell proliferation and excessive angiogenesis.